Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 11:13:57.
doi: 10.3389/fnins.2019.00057. eCollection 2019.

Sex Hormones and Optic Nerve Disorders: A Review

Affiliations
Review

Sex Hormones and Optic Nerve Disorders: A Review

Raffaele Nuzzi et al. Front Neurosci. .

Abstract

Aim: This review article presents a comprehensive overview of the literature on sex hormones (estrogens, androgens, progesterone) and optic nerve disorders, with a discussion of the implications for therapy and prevention. Methods: Epidemiological, pre-clinical and clinical studies were reviewed. Results: Analysis of the biological basis for a relationship between eye diseases and sex hormones showed that some types of hormones can exert a protective effect either directly on the retina and optic nerve or indirectly by modulating ocular blood flow. For example, it seems that estrogen exposure has a protective effect against glaucoma, whereas its deficit may lead to early onset of the disease. If further studies confirm the data in the literature, estrogen therapy, because of its antioxidant action, may be effective in the treatment of Leber's hereditary optic neuropathy, whereas, in the light of current studies, there does not seem to be an influence of estrogen on non-arteritic anterior ischemic optic neuritis (NAION). Conclusions: Although there is some evidence that in some optic nerve pathologies the sex hormones seem to play an important role there are still too few studies providing evidence for its wider use in clinical practice.

Keywords: estrogens; eye disorders; glaucoma; gonadal hormones; hormone therapy; optic nerve diseases; sex-related differences.

PubMed Disclaimer

References

    1. Akar M. E., Taskin O., Yucel I., Akar Y. (2004). The effect of the menstrual cycle on optic nerve had analysis in healthy women. Acta Ophthalmol. Scand. 82, 741–745. 10.1111/j.1600-0420.2004.00351.x - DOI - PubMed
    1. Akar M. E., Yucel I., Erdem U., Taskin O., Ozel A., Akar Y. (2005a). Effect of the menstrual cycle on the optic nerve head in diabetes: analysis by confocal scanning laser ophthalmoscopy. Can. J. Ophthalmol. 40, 175–182. 10.1016/S0008-4182(05)80029-8 - DOI - PubMed
    1. Akar Y., Yucel I., Akar M. E., Zorlu G., Ari E. S. (2005b). Effect of pregnancy on intraobserver and intertechnique agreement in intraocular pressure measurements. Ophthalmologica 219, 36e−42e. 10.1159/000081781 - DOI - PubMed
    1. Altinta S. O., Caglar Y., Yuksel N., Demirci A., Karabaş L. (2004). The effects of menopause and hormone replacement therapy on quality and quantity of tear, intraocular pressure and blood flow. Ophthalmologica 218, 120–129. 10.1159/000076148 - DOI - PubMed
    1. Andersen L., Friis S., Hallas J., Ravn P., Gaist D. (2013a). Hormone replacement therapy and risk of glioma: a nationwide nested case-control study. Cancer Epidemiol. 37, 876–880. 10.1016/j.canep.2013.09.017 - DOI - PubMed